Research advances in the pathogenesis of metabolic associated fatty liver disease

Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 10

Abstract

Metabolic associated fatty liver disease (MAFLD) is currently the most common liver disease around the world. MAFLD may easily progress to the adverse outcomes such as hepatitis, liver fibrosis, and liver cirrhosis, and it is often accompanied by comorbidities such as diabetes, hypertension, hyperlipidemia, hyperuricemia, and cardiovascular and cerebrovascular diseases. Etiological treatment is the cornerstone of MAFLD treatment, and due to the complexity and adverse outcome of MAFLD, it is of great significance to explore the pathogenesis of MAFLD and develop effective prevention and treatment regimens and drugs. This article reviews the pathogenesis of MAFLD from the aspects of genetic factors, improper diet and oxidative stress, spleen-stomach damp-heat and insulin resistance, damp-heat and pathogenic Qi, organic acid metabolism, and intestinal microecology.

Authors and Affiliations

Shukun YAO, Jing LIU, Tianhui ZHOU

Keywords

Related Articles

High-risk factors for early postoperative recurrence of hepatocellular carcinoma and related prediction methods

Hepatocellular carcinoma (HCC) is a malignant tumor with high incidence and mortality rates, and although surgical resection is a possible method for cure, the prognosis of HCC is still affected by its high recurrenc...

Research advances in the mechanism of action of nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome in autoimmune hepatitis

Autoimmune hepatitis (AIH) is chronic hepatitis caused by the attack of live cells by the immune system, and at present, the pathogenesis of AIH remains unclear. Inflammasomes are important components of innate immun...

The association between gallstone and biliary pancreatitis

Acute pancreatitis is one of the most common acute abdominal diseases in clinical practice, and the common etiologies of acute pancreatitis include biliary diseases, alcohol, pancreatic duct diseases, metabolic disor...

Current status of the application of artificial intelligence in the diagnosis and treatment of pancreatic cancer

Pancreatic cancer is a common malignant tumor of the digestive system, with a low early diagnosis rate, a high surgical mortality rate, a low cure rate, and a poor overall prognosis. In recent years, with the contin...

Efficacy and safety of tenofovir alafenamide fumarate in patients with first-time hepatitis B virus-related decompensated cirrhosis

[Objective] To investigate the application value of tenofovir alafenamide fumarate (TAF) in patients with first-time hepatitis B virus-related decompensated cirrhosis (HBV-DC) and its impact on renal function and lip...

Download PDF file
  • EP ID EP751077
  • DOI 10.12449/JCH241005
  • Views 19
  • Downloads 0

How To Cite

Shukun YAO, Jing LIU, Tianhui ZHOU (2024). Research advances in the pathogenesis of metabolic associated fatty liver disease. Journal of Clinical Hepatology, 40(10), -. https://europub.co.uk/articles/-A-751077